サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1336715

喉頭鏡の世界市場-2023年～2030年

Global Laryngoscopes Market - 2023-2030
出版日: | 発行: DataM Intelligence | ページ情報: 英文 195 Pages | 納期: 約2営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.76円
喉頭鏡の世界市場-2023年～2030年
出版日: 2023年08月22日
発行: DataM Intelligence
ページ情報: 英文 195 Pages
納期: 約2営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

市場概要

喉頭鏡の世界市場は2022年に3億米ドルに達し、2023-2030年の予測期間にCAGR 16.6％で成長し、2030年には11億米ドルに達すると予測されています。

喉頭鏡は声帯を観察し、直接目で見ながら気管内チューブを気管に挿入するために使用されます。喉頭鏡検査は生理反射の大幅な活性化を引き起こすため、徹底した麻酔が必要であり、呼吸器系、心血管系、神経系の合併症が起こりやすいです。高血圧の人、妊娠中の高血圧患者、虚血性心疾患のある人は最も危険です。深麻酔、局所麻酔薬、アトロピンやリドカイン静注などの薬物による交感神経副腎反応の防止、機械的刺激の最小化などはすべて、悪影響を軽減するのに役立ちます。

さらに、喉頭鏡市場は、呼吸器疾患の増加や医療費の上昇を抑える圧力の高まり、質の高い患者ケアへのニーズの高まり、低侵襲手術への需要の高まりなど、さまざまな要因によって牽引されています。

ダイナミクス

喉頭がん有病率の上昇

喉頭がんの有病率の増加は、予測期間中に市場が成長するのに役立つ重要な主要な要因の1つです。一般的な喉頭疾患には、喉頭炎、声帯結節、声帯ポリープ、ラインケ浮腫、喉頭蓋嚢腫などがあります。さらに、喉頭疾患の有病率は男性で高いことが観察されています。

例えば、米国がん協会によると、2023年には米国で約12,470例（男性9,990例、女性2,480例）の喉頭がんが新たに発生すると推定しています。喉頭がんの約60％は声門（声帯を含む部分）から発生し、約35％は声門上（声帯の上方）で発生します。

喉頭内視鏡検査では、声帯や喉の近傍の生検サンプルを採取し、さらにがんを検出します。このように、喉頭疾患の有病率の増加は、喉頭鏡市場を世界的に加速させる態勢を整えており、今後も増加すると予想されるため、予測期間中に調査された市場の成長を促進します。

技術進歩の上昇

技術進歩の上昇が予測期間中の市場成長を促進します。例えば、2023年1月、Timesco Healthcare Ltdは、Arab Health 2023で新しいOptima Viewビデオ喉頭鏡を発表しました。

この革新的なシステムは、高解像度カメラとビデオ・ディスプレイ・モニターを搭載し、鮮明で色彩の正確な出力を提供します。3.75インチLCDディスプレイは180度回転し、110度傾くので、複数のビューアーで簡単に見たり、教えたりすることができます。

喉頭鏡の高コスト

喉頭鏡市場の成長を制限する主な要因の1つは、新興国での麻酔用ビデオ喉頭鏡の採用が少ないことです。高価なコストと、適用範囲を提供する有利な償還政策がないためです。メドトロニックの統計によると、再利用可能なデバイスのコストは、その技術的専門性によって1,000～8,000米ドルであり、標準的な喉頭鏡のシングルユースのコストは18米ドルです。

その結果、これらの器具の法外な価格とその維持費が、事業拡大を阻害しています。同時に、気管内挿管用の費用対効果の高い代替器具が入手可能であることも、この市場の潜在的発展の大きな障害となっています。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
      • 喉頭がんの有病率の上昇
      • 技術進歩
    • 抑制要因
      • 喉頭鏡の高コスト
    • 機会
      • ロボット支援喉頭鏡
    • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 価格分析
  • 規制分析

第6章 COVID-19分析

第7章 タイプ別

  • 直接喉頭鏡
  • 間接喉頭鏡

第8章 製品別

  • 標準型喉頭鏡
  • 光ファイバー喉頭鏡

第9章 エンドユーザー別

  • 病院
  • 診療所
  • 検診センター

第10章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他アジア太平洋
  • 中東・アフリカ

第11章 競合情勢

  • 競合シナリオ
  • 市況/シェア分析
  • M&A分析

第12章 企業プロファイル

  • Ambu A/S
    • 会社概要
    • 製品ポートフォリオと説明
    • 財務概要
    • 主な動向
  • Flexicare Medical
  • NOVAMED USA
  • Penlon Limited
  • Rudolf Riester GmbH
  • Medtronic plc.
  • Propper Manufacturing Co. Inc
  • Teleflex Incorporated
  • Verathon Inc.
  • KARL STORZ GmbH & CoNovelda AS

第13章 付録

目次
Product Code: MD3675

Market Overview

Global laryngoscopes market reached US$ 0.3 billion in 2022 and is expected to reach US$ 1.1 billion by 2030 growing with a CAGR of 16.6% during the forecast period 2023-2030.

Laryngoscopes are used to see the vocal cords and insert the endotracheal tube into the trachea under direct eyesight. Since laryngoscopy induces substantial activation of physiologic reflexes, thorough anaesthesia is required, and respiratory, cardiovascular, and neurologic complications are likely. Hypertensive individuals, pregnant hypertensive patients, and people with ischemic heart disease are most vulnerable. Deep anaesthesia, topical anaesthetics, preventing the sympathoadrenal response with medications like atropine or intravenous lidocaine, and minimising mechanical stimulation can all help to mitigate the negative consequences.

Furthermore, the laryngoscopes market is driven by various factors like increasing respiratory diseases and growing pressure to reduce the rising healthcare costs, increasing need for high-quality patient care, and increasing demand for minimally invasive surgeries.

Dynamics

Rise in the prevalence of laryngeal cancer

The rise in the prevalence of laryngeal cancer is one of the significant key driver that helps the market to grow during the forecast period. Some common laryngeal diseases include laryngitis, vocal nodules, vocal polyps, Reinke's edema, and epiglottic cyst, among others. In addition, it has been observed that the prevalence of laryngeal disease is higher in males.

For instance, according to the American Cancer Society, it estimates in 2023, there will be about 12,470 new cases of laryngeal cancer (9,990 in men and 2,480 in women) in the United States. About 60% of laryngeal cancers start in the glottis (the area containing the vocal cords), while about 35% develop in the supraglottic area (above the vocal cords).

Laryngoscopy takes biopsy samples of the vocal cords or nearby parts of the throat to detect cancer further. Thus, the increasing prevalence of laryngeal disease is poised to accelerate the laryngoscope market globally and is expected to increase in the future, thereby driving the growth of the market studied over the forecast period.

Rise in Technological Advancements

A rise in technological advancement will drive market growth during the forecast period. For instance, in Jan 2023 Timesco Healthcare Ltd launched its new Optima View video laryngoscope at Arab Health 2023, aiming to improve visualisation, reduce complications, and improve tracheal intubation success rates in prehospital settings.

The innovative system features a high-resolution camera and video display monitor, offering clear, colour-correct output. The 3.75" LCD display rotates 180 degrees and tilts 110 degrees, allowing for easy viewing and teaching with multiple viewers.

High Cost of Laryngoscopes

One of the key factors limiting the growth of the laryngoscope market is the lesser adoption of anaesthesia video laryngoscopes in emerging nations due to expensive costs and a lack of favourable reimbursement policies to offer coverage. According to Medtronic statistics, the cost of reusable devices ranges from USD 1,000 to USD 8,000 depending on their technological speciality, compared to the cost of a single-use standard laryngoscope, which is USD 18.

As a result, the exorbitant prices of these gadgets, as well as their upkeep, are poised to stymie expansion. At the same time, the availability of cost-effective alternative devices for endotracheal intubations is a big impediment to this market's development potential.

Segment Analysis

The global laryngoscopes is segmented based on type, product, end user and region.

The Direct Laryngoscopes From the Type Segment Accounted for Approximately 42.1% of the Laryngoscopes Share

The direct laryngoscopes from the type segment with around 42.1% are expected to dominate during the forecast period. A direct laryngoscopy allows visualization of the larynx and is often used during general anaesthesia, surgical procedures around the larynx, and resuscitation. This tool is useful in multiple hospital settings, from the emergency department to the intensive care unit and the operating room.

This procedure is used during general anaesthesia, surgical procedures around the larynx, and resuscitation, and it facilitates endotracheal intubation, which is an important step for patients who are unable to secure their own airways. However, direct laryngoscopy should only be attempted if preparations are in place for an immediate surgical airway if intubation is unsuccessful.

Geographical Penetration

North America Accounted for Approximately 38.4% of the Market Share in 2022

North America is estimated to hold about 38.4 % of the total market share throughout the forecast period, owing to the new launches, increased investments by large corporations and expansion strategies like mergers, acquisitions, and the introduction of novel products by market participants.

For instance, in April 2023, Verathon, a global leader in airway management solutions, announced the launch of the GlideScope Spectrum QC with QuickConnect technology. This new, extensive portfolio of single-use video laryngoscopes features a unique, magnetic connector coupled with image quality enhancements to support fast, effective airway management.

The integration of QuickConnect technology with the market-leading GlideScope Spectrum video laryngoscopes further optimizes prep time for intubation procedures, especially important in emergent and difficult airway management situations. QuickConnect ensures the clinician can focus on the patient while utilizing the AlwaysConnect experience.

Competitive Landscape

The major global players in the laryngoscopes market include Ambu A/S, Flexicare Medical, NOVAMED USA, Penlon Limited, Rudolf Riester GmbH, Medtronic plc, Propper Manufacturing Co. Inc, Teleflex Incorporated, Verathon Inc, KARL STORZ GmbH & Co and among others.

COVID-19 Impact Analysis

The COVID-19 epidemic had little influence on the laryngoscope market. The severe lockdowns and government measures enacted to halt the spread of COVID-19 resulted in a decrease in the number of patients seeking non-emergency care. COVID-19, on the other hand, largely impacted the respiratory system, resulting in an instant need for respiratory and vascular access equipment, such as laryngoscopes.

Furthermore, the UK Difficult Airway Society, the Association of Anaesthetists, the Intensive Care Society, and the Royal College of Anaesthetists have all recommended tracheal intubation with a video laryngoscope over a direct laryngoscope for patients with suspected or confirmed COVID-19 who require intubation.

Russia Ukraine Conflict Analysis

The Russia-Ukraine conflict is estimated to have a moderate impact on the global laryngoscopes market, owing to the low prevalence and absence of key market players in this region. However, the impact of the import and export of devices is expected to have little influence over the global laryngoscopes market growth over the forecast period.

By Type

  • Direct Laryngoscopes
  • Indirect Laryngoscopes

By Product

  • Standard Laryngoscopes
  • Fiber-optic Laryngoscopes

By End User

  • Hospitals
  • Clinics
  • Medical Examination Center

By Region

  • North America

U.S.

Canada

Mexico

  • Europe

Germany

U.K.

France

Spain

Italy

Rest of Europe

  • South America

Brazil

Argentina

Rest of South America

  • Asia-Pacific

China

India

Japan

Australia

Rest of Asia-Pacific

  • Middle East and Africa

Key Developments

  • In April 2022, OmniVision, a global semiconductor developer, launched new laryngoscope reference designs featuring clear images for single-use video laryngoscopes. This visualization improves patient care by making insertion easier and faster, reducing complications and even death risks in difficult airways.
  • In July 2022, Zsquare, a leading developer of high-performance, single-use endoscopes, announced that it received FDA clearance to market its first product, the Zsquare ENT-Flex Rhinolaryngoscope.
  • On March 28 2022, Mercury Medical selected Andau Medical as their Canadian Airtraq Video Laryngoscope System Distribution Partner with the signing of an Exclusive Agreement. Mercury Medical, the exclusive North American distributor of the Airtraq video laryngoscope and camera system, has selected Andau Medical as their exclusive Canadian distribution partner for the state-of-the-art Airtraq video laryngoscope product line.

Why Purchase the Report?

  • To visualize the global laryngoscopes market segmentation based on type, product, end user and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of laryngoscopes market level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The global laryngoscopes report would provide approximately 53 tables, 54 figures and 195 pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Type
  • 3.2. Snippet by Product
  • 3.3. Snippet by End User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rise in the Prevalence of Laryngeal Cancer
      • 4.1.1.2. Rise in Technological Advancements
    • 4.1.2. Restraints
      • 4.1.2.1. High Cost of Laryngoscopes
    • 4.1.3. Opportunity
      • 4.1.3.1. Robotic Assisted Laryngoscopes
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's 5 Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID-19
    • 6.1.2. Scenario During COVID-19
    • 6.1.3. Scenario Post Covid-19
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 7.1.2. Market Attractiveness Index, By Type
  • 7.2. Direct Laryngoscopes *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Indirect Laryngoscopes

8. By Product

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 8.1.2. Market Attractiveness Index, By Product
  • 8.2. Standard Laryngoscopes*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Fiber-optic Laryngoscopes

9. By End User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.1.2. Market Attractiveness Index, By End User
  • 9.2. Hospitals *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Clinics
  • 9.4. Medical Examination Center

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Spain
      • 10.3.6.5. Italy
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. Ambu A/S*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. Flexicare Medical
  • 12.3. NOVAMED USA
  • 12.4. Penlon Limited
  • 12.5. Rudolf Riester GmbH
  • 12.6. Medtronic plc.
  • 12.7. Propper Manufacturing Co. Inc
  • 12.8. Teleflex Incorporated
  • 12.9. Verathon Inc.
  • 12.10. KARL STORZ GmbH & CoNovelda AS

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us